Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
Clinical trial NCT03351062 · UNKNOWN
Trial details
- NCT number
- NCT03351062
- Sponsor
- Chinese Anti-Cancer Association
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2025-12-01
- Enrollment
- 844
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.